Meningococcal vaccine for infants?
Campos-Outcalt, D.
Journal of Family Practice 61(8): 482-484
2012
ISSN/ISBN: 1533-7294 PMID: 22871657 Document Number: 658103
With the incidence of meningococcal disease declining in all age groups, ACIP is weighing the need for vaccination in children <2 years.
Document emailed within 1 workday
Related Documents
Pereiró, I.; Díez-Domingo, J.; Morant, A.; Gimeno, C.; Lerma, M.; San-Martín, M.; González, A. 2001: Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine Scandinavian Journal of Infectious Diseases 33(8): 581-584Kintu, K.; Andrew, P.; Musoke, P.; Richardson, P.; Asiimwe-Kateera, B.; Nakyanzi, T.; Wang, L.; Fowler, M.G.; Emel, L.; Ou, S.-S.; Baglyos, L.; Gurunathan, S.; Zwerski, S.; Jackson, J.B.; Guay, L. 2013: Feasibility and safety of ALVAC-HIV vCP1521 vaccine in HIV-exposed infants in Uganda: results from the first HIV vaccine trial in infants in Africa Journal of Acquired Immune Deficiency Syndromes 63(1): 1-8
Basnak'ian, I.A.; Aleksakhina, N.N. 2006: Perspectives for development of polyvalent meningococcal vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 7: 54-58
Dong, B.-q.; Ye, Q.; Cui, X.-l.; Yang, J.; Gong, J.; Yang, M.; Liao, H.-z.; Wei, S.-l.; Zhang, J.; Wu, X.-h.; Si, G.-a.; Yang, H.-h.; Tsuzuki, A.; Park, J.; Ali, M.; Ochiai, L.R.; Clemens, J.D. 2007: Evaluation on the safety of a group a + C meningococcal polysaccharide vaccine Zhonghua Liu Xing Bing Xue Za Zhi 28(5): 417-421
Bahl, R.; Kumar, R.; Bhandari, N.; Kant, S.; Srivastava, R.; Bhan, M.K. 1999: Vitamin a administered with measles vaccine to nine-month-old infants does not reduce vaccine immunogenicity Journal of Nutrition 129(8): 1569-1573
Pérez Rodríguez, A.; Meneses, F.O. 1999: VA-MENGOC-BC vaccine: its impact on meningococcal disease in children 1-4 years old Revista Cubana de Medicina Tropical 51(3): 189-193
Troy, S.B.; Musingwini, G.; Halpern, M.S.; Huang, C.; Stranix-Chibanda, L.; Kouiavskaia, D.; Shetty, A.K.; Chumakov, K.; Nathoo, K.; Maldonado, Y.A. 2013: Vaccine poliovirus shedding and immune response to oral polio vaccine in HIV-infected and -uninfected Zimbabwean infants Journal of Infectious Diseases 208(4): 672-678
Pérez-Martín, O.; Lastre-González, M.; Díaz-Orellana, M.; Zayas-Vignier, C.; Caso, R.; Hernández, I.; Sierra-González, G. 1997: Biodistribution of the Cuban anti-meningococcal vaccine, VA-MENGOC-BC, in Balb/c mice Archives of Medical Research 28(1): 37-40
Bremner, C.; Lennon, D.; Martin, D.; Baker, M.; Rümke, H. 1999: Epidemic meningococcal disease in New Zealand: epidemiology and potential for prevention by vaccine New Zealand Medical Journal 112(1091): 257-259
Mounier-Jack, S.; Burchett, H.E.D.; Griffiths, U.K.; Konate, M.; Diarra, K.S. 2014: Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system Global Health Science and Practice 2(1): 117-129
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
1977: Biofeedback for fecal incontinence. Meningococcal vaccine found effective. Very young children may be immunized JAMA 238(24): 2595-2596
Lin, T.-Y.; Wang, Y.-H.; Chang, L.-Y.; Chiu, C.-H.; Huang, Y.-C.; Tang, H.; Bock, H.L. 2003: Safety and immunogenicity of a diphtheria, tetanus, and acellular pertussis-inactivated poliovirus vaccine/Haemophilus influenzae type B combination vaccine administered to Taiwanese infants at 2, 4, and 6 months of age Chang Gung Medical Journal 26(5): 315-322
Turhan, V.; Acar, A.; Kılıç, A.; Budak, S.; Oncül, O.; Haznedaroğlu, T.çe.; Görenek, L. 2010: Meningococcemia and meningitis due to Neisseria meningitidis W135 developed in two cases vaccinated with bivalent (A/C) meningococcal vaccine Mikrobiyoloji Bulteni 44(3): 473-478
de Soarez, P.Coelho.; Sartori, A.Marli.C.; de Andrade Lagoa Nóbrega, L.; Itria, A.; Novaes, H.Maria.Dutilh. 2011: Cost-effectiveness analysis of a universal infant immunization program with meningococcal C conjugate vaccine in Brazil Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 14(8): 1019-1027
Pérez Rodríguez, A.; Dickinson Meneses, Félix.; Rodríguez Ortega, M. 2011: Effectiveness of the anti-meningococcal vaccine VA-MENGO-BC in the first year of life of Cuban children, 1997-2008 Revista cubana de medicina tropical 63(2): 155-160
Basnak'ian, I.A.; Alliluev, A.P.; Kuvakina, V.I.; Aleksakhina, N.N.; Kotel'nikova, O.V.; Chulok, T.A.; Karabak, V.i.; Borovkova, V.M.; Valerius, I.I.; Gofman, I.L. 1994: The immunological activity of a meningococcal serogroup-B polysaccharide-protein vaccine with a prolonged storage time in single administration Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 66-67
Saliou, P.; Stoeckel, P.; Lafaye, A.; Rey, J.L.; Renaudet, J. 1978: Controlled tests of anti-meningococcal polysaccharide a vaccine in the African Sahel area (Upper Volta and Mali) Developments in Biological Standardization 41: 97-108
Ali, M.; Emch, M.; Yunus, M.; Sack, D.; Lopez, A.L.; Holmgren, J.; Clemens, J. 2008: Vaccine Protection of Bangladeshi infants and young children against cholera: implications for vaccine deployment and person-to-person transmission Pediatric Infectious Disease Journal 27(1): 33-37
Shek, L.Pei.Chi.; Khor, E.Sek.Hoon.; Tan, G.Huat.; Low, K.Tzay.; Ong, D.; Roy, J.; Han, H.Htay.; Bock, H.Ludwig.; Lee, B.Wah. 2003: Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants Southeast Asian Journal of Tropical Medicine and Public Health 34(4): 863-868